Eurofirst News: Eurofirst 100, Eurofirst 250, and Eurofirst 500 investment news
Eurofirst market news from the Euronext Stock Exchange: Eurofirst 100, Eurofirst 250, and Eurofirst 400

Latest Eurofirst News:

  • European carmakers higher on Nissan gains

  • IBEX adds 1.42 percent on session

  • France Telecom gains over 8.5 percent on results

  • Banks see declines in Europe

  • European equities lower on renewed subprime worries

  • IBEX gains again amid European equities declines

  • Truck maker Man up on bids rumors

  • IBEX gains almost 1 percent on session

  • European utilities gain again

  • European equities lower on session

  • Euronext news feed


    Recommended equities news sites

  • Euronext
  • Euro Watch
  • FTSE News
  • Tokyo Market News
  • NYSE News
  • Mortgages & Loans
  •  

    July 20, 2006

    Electronics mixed in Europe

    Filed under: ASML, Sandvik, Roche, Atlas Copco, Nokia, Ericsson

    The FTSE Eurofirst 300 was 0.2 percent higher on Thursday, gaining only 2.3 points on the session to 1,301.6. Quarterly reports and broker recommendations were key factors in the gains and losses of individuals stocks.

    Nokia added 0.4 percent to €15.62 after it released its second-quarter earnings report. Before the figures were released, shares in the Finnish mobile handset manufacturer went as high as €16.08. Later on, they fell as low as €15 before rising a bit before the close of trade. Meanwhile, Ericsson was down 0.9 percent to SKr23 ahead of its quarterly report, which is due to be released on Friday.

    In the semiconductor sector, chip equipment maker ASML was 2.2 percent lower to €15.56 after a gain of over 6 percent yesterday after it released a positive quarterly report. Despite the report, Rabo Securities downgraded ASML’s shares from “buy” to “hold”.

    Swedish engineering company Sandvik dropped 4.2 percent to SKr73.75 after its quarterly report failed to meet expectations. Elsewhere in the sector, Atlas Copco was down 2.5 percent to SKr176.50 after a disappointing guidance was released earlier this week.

    In the pharmaceuticals sector, Roche added 3.3 percent to SFr214.90, its highest closing price ever, helped by a good quarterly report. Bear Stearns confirmed its “outperform” rating and SFr280 target share price for the drug maker. Dresdner Kleinwort did not change its “sell” rating, but raised Roche’s target share price from SFr170 to SF4180.





    Latest Equities News:

  • Europe, US, most Asia markets lower on news, data

  • Equities decline globally on European debt concerns

  • Most global equities markets see declines on commodities prices

  • Europe, Asia markets mixed as Wall Street declines

  • European, US markets see gains as Asia markets remain mixed

  • European equities decline on lower credit rating for Greece

  • European equities markets gain, helped by US jobs report

  • Most global equities markets in decline

  • Europe, US, Asia markets all see declines

  • London markets see gains as most European markets retreat

  • Eurofirst News copyright 2012 Central Consultants